Common TitleAI424-009
Official Title Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, Atazanavir (BMS-232632), in Combination Regimen(s) as Compared to a Reference Combination Regimen(s) in Antiretroviral-Experienced HIV-Infected Subjects
Phase Phase II
ClinicalTrials.gov NCT00004584
Treatments
Atazanavir
, Atazanavir
Tradename:ReyatazOther Names:ATVClass:Protease Inhibitors (PI)Saquinavir
Saquinavir
Tradename:InviraseOther Names:SQVClass:Protease Inhibitors (PI)Categories Resistance/Virological FailurePharmacologyTreatment-ExperiencedAdverse Effects
Funding
IndustryBristol-Myers Squibb
References
- Haas DW, Zala C, Schrader S, et al. Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial. AIDS. 2003;17:1339-49.